MDPHP is believed to act generally for a powerful norepinephrine-dopamine reuptake inhibitor (NDRI). Decreased re-uptake of norepinephrine and dopamine leads to bigger concentrations of the two catecholamine neurotransmitters inside the synaptic cleft, or gap in between neurons. The result of this i